Increased Medication Burden for Patients With Both Asthma and Allergies
Patients with both asthma and allergies had a significant increase in the number of prescriptions dispensed for controller medications.
All articles by Cardiology Advisor Contributing Writer
Benralizumab Reduces Rescue Medication Use in Severe Eosinophilic Asthma
By day 3, patients with severe eosinophilic asthma who received benralizumab required less use of rescue medication.
GSP301 Nasal Spray Improves QoL in Seasonal Allergic Rhinitis
Patients who received a fixed-dose combination nasal spray showed significantly improved Physician-assessed Nasal Symptom Scores compared with those who received placebo.
Dupilumab Improves Asthma Control Regardless of Exacerbation History
Better asthma control, as indicated by lower mean scores on the Asthma Control Questionnaire-5, were seen in both the dupilumab and placebo groups.
Does Prearrival Epinephrine Adversely Affect Pediatric Anaphylaxis Patients?
Despite many pediatric patients receiving higher than recommended doses of epinephrine for their weight, they did not present with epinephrine-related symptoms.
Does Cetirizine Provide More Benefits Than Diphenhydramine for Acute Urticaria?
The change from baseline in 2-hour pruritus score was shown to be statistically noninferior from IV cetirizine to IV diphenhydramine, in favor of IV cetirizine.
Combo Tx May Improve Anticoagulant Activity, Reduce Hypertensive Damage
Coagulant activity was improved with the use of both anticoagulation and antihypertensive therapies in combination.
Combining NSAIDs With Oral Anticoagulants Increases Bleeding Risk in AF
While the use of NSAIDs was low in the ARISTOTLE trial, NSAID users had a higher risk for bleeding than non-users.
Calcium Channel Blockers May Reduce Peripheral Arterial Disease Risk
Meta-analysis suggests that calcium channel blockers can be effective in preventing peripheral arterial disease in patients with hypertension.
High Susceptibility Antibiotics Reduce Readmission Rates for UTIs
The use of a moderate to low susceptibility antibiotic to treat a urinary tract infection [UTI] may result in a 1.74-fold increase in the odds of an emergency department readmission within 30 days for another UTI.
